Literature DB >> 26337717

Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature.

Stefano Molica1, Luciano Levato1, Rosanna Mirabelli1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26337717     DOI: 10.3109/10428194.2015.1071489

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  5 in total

Review 1.  Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.

Authors:  Jon E Arnason; Jennifer R Brown
Journal:  Curr Oncol Rep       Date:  2017-09       Impact factor: 5.075

2.  Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.

Authors:  Candida Vitale; Inhye E Ahn; Mariela Sivina; Alessandra Ferrajoli; William G Wierda; Zeev Estrov; Sergej N Konoplev; Nitin Jain; Susan O'Brien; Mohammed Farooqui; Michael J Keating; Adrian Wiestner; Jan A Burger
Journal:  Haematologica       Date:  2016-03-24       Impact factor: 9.941

Review 3.  Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.

Authors:  Christopher Pleyer; Adrian Wiestner; Clare Sun
Journal:  Leuk Lymphoma       Date:  2018-05-15

4.  Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma.

Authors:  Aliénor Galinier; Vincent Delwail; Mathieu Puyade
Journal:  Case Rep Oncol       Date:  2017-01-27

Review 5.  Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.

Authors:  Candida Vitale; Maria Chiara Montalbano; Chiara Salvetti; Elia Boccellato; Valentina Griggio; Mario Boccadoro; Marta Coscia
Journal:  Cancers (Basel)       Date:  2020-01-23       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.